Tribunal rules in favor of assessee, categorizing share sale gain as capital, allows R&D deduction

The Tribunal ruled in favor of the assessee, directing the AO to treat the gain on the sale of shares as short-term capital gain rather than business income. Additionally, the Tribunal instructed the AO to allow the weighted deduction for Research and Development expenses under section 35(2AB) of the Income Tax Act. The decision highlighted the significance of evaluating various factors and legal precedents to determine income nature and eligibility for deductions.

---

---

Issues Involved:
1. Treatment of gain on sale of shares as business income vs. short-term capital gain.
2. Disallowance of weighted deduction under section 35(2AB) of the Income Tax Act for Research and Development expenses.

Issue-Wise Detailed Analysis:

1. Treatment of Gain on Sale of Shares:
The assessee, a private limited company engaged in manufacturing and selling biomass gasifiers, filed its return of income declaring a total income of Rs. 3,44,94,749/-. The dispute arose when the Assessing Officer (AO) treated the gain on the sale of shares amounting to Rs. 28,24,217/- as business income instead of short-term capital gain as claimed by the assessee. The AO's decision was based on the frequency and volume of transactions, suggesting the assessee was trading in shares rather than investing.

The Tribunal considered various principles and judicial pronouncements, including the tests laid out by ITAT Lucknow Bench in Sarnath Infrastructure Pvt. Ltd. and the Gujarat High Court in Commissioner of Income Tax vs. Riva Sharkar A Kothari. These tests include the intention at the time of purchase, frequency of transactions, treatment in books of accounts, and whether the transactions were for realizing profit or for investment purposes.

The assessee argued that:
- It is primarily a manufacturing company, not engaged in trading shares.
- Investments were made in blue-chip companies, indicating a long-term investment intent.
- Transactions were delivery-based, and no borrowed funds were used for investments.
- Investments were consistently valued at cost, and the same practice was followed in previous years without dispute from the department.

The Tribunal concluded that the cumulative factors, including the nature of transactions, the method of accounting, and the primary business of the assessee, indicated that the assessee was an investor, not a trader. The Tribunal directed the AO to treat the gain of Rs. 28,24,217/- as short-term capital gain.

2. Disallowance of Weighted Deduction under Section 35(2AB):
The assessee claimed a weighted deduction of Rs. 13,48,732/- for Research and Development (R&D) expenses under section 35(2AB) of the Income Tax Act. The AO disallowed the claim on two grounds:
- The Department of Science & Industrial Research (DSIR) approved the R&D facility from 1st April 2010, which the AO interpreted as applicable only from AY 2011-12.
- The assessee did not maintain separate accounts for the approved R&D facility as required by Rule 6(7A)(c) of the Income Tax Rules.

The Tribunal examined the submissions and noted that:
- The assessee's R&D unit had been recognized by DSIR since 1990, with the latest renewal valid from 1st April 2009 to 31st March 2012.
- The Gujarat High Court in CIT Vs. Claris Lifesciences Ltd. held that the Act does not provide for a specific cut-off date for weighted deduction eligibility. The approval by DSIR is sufficient to claim the deduction for the entire period.
- The assessee maintained separate ledger accounts for R&D expenses, certified by Chartered Accountants, fulfilling the requirement of separate accounts.

The Tribunal found that the AO's disallowance was not justified as the assessee met the conditions under section 35(2AB) and Rule 6(7A). The Tribunal directed the AO to allow the weighted deduction of Rs. 13,48,732/-.

Conclusion:
The Tribunal allowed the appeal of the assessee, directing the AO to treat the gain on the sale of shares as short-term capital gain and to grant the weighted deduction for R&D expenses under section 35(2AB). The decision emphasized the importance of considering the cumulative factors and judicial precedents in determining the nature of income and eligibility for deductions.

---